Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $5.48M invested in Bio-Rad Laboratories Class B in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
14% more capital invested
Capital invested by funds: $4.79M → $5.48M (+$688K)
0.01% more ownership
Funds ownership: 0.58% → 0.58% (+0.01%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$189K |
| 2 |
ACM
Armbruster Capital Management
Pittsford,
New York
|
+$3.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$124K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $4.09M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.17M | – | – | – |
|
|
3
Renaissance Technologies
New York
| $201K | +$189K | +1,100 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $12K | -$124K | -723 | -92% |
|
|
ACM
5
Armbruster Capital Management
Pittsford,
New York
| $4K | +$3.77K | +22 | New |
|
6
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
BIO.B Hedge Fund Activity: Q4 2016 in Review
6 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2016, worth a combined $5.48M — up 14% from $4.79M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIO.B positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $189K. The largest seller was UBS Group, cutting an estimated $124K.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2016, up from 4 in Q3 2016.
- Funds reported $5.48M of Bio-Rad Laboratories Class B stock for Q4 2016, up 14% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q4 2016 and 0 closed out, a net change of +2 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2016 was Renaissance Technologies, an estimated $189K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2016 was UBS Group, an estimated $124K sold.
Based on aggregated 13F filings for Q4 2016.